HEPION PHARMACEUTICALS, INC. Basic Shares Outstanding (Weighted Average)
HEPION PHARMACEUTICALS, INC. (HEPA) reported Basic Shares Outstanding (Weighted Average) of 16.19 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfSharesOutstandingBasic · last filed 2026-08-13
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-06-30 was 16.19M shares, a 42.95% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2026-03-31 was 11.62M shares, a 309.64% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-12-31 was 11.68M shares, a 8280.02% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for the quarter ending 2025-09-30 was 11.62M shares, a 8547.42% increase year-over-year.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2025 was 9.41M shares, a 7556.50% increase from fiscal 2024.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2024 was 122.89K shares, a 54.75% increase from fiscal 2023.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2023 was 79.42K shares, a 97.92% decline from fiscal 2022.
- HEPION PHARMACEUTICALS, INC. weighted average number of shares outstanding, basic for fiscal 2022 was 3.81M shares, a 94.58% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Basic 3 month | Weighted Average Number of Shares Outstanding, Basic 3 month as first filed | Weighted Average Number of Shares Outstanding, Basic 6 month | Weighted Average Number of Shares Outstanding, Basic 6 month as first filed | Weighted Average Number of Shares Outstanding, Basic 9 month | Weighted Average Number of Shares Outstanding, Basic 9 month as first filed | Weighted Average Number of Shares Outstanding, Basic 12 month | Weighted Average Number of Shares Outstanding, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 16.19M shares 10-Q · filed 2026-08-13 | 13.91M shares 10-Q · filed 2026-08-13 | 13.16M shares derived: average of 3 quarters · filed 2026-08-13 | 12.78M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | 11.62M shares 10-Q · filed 2026-05-14 | 11.65M shares derived: average of 2 quarters · filed 2026-05-14 | 11.64M shares derived: average of 3 quarters · filed 2026-05-14 | 11.56M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | 11.68M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 11.65M shares derived: average of 2 quarters · filed 2026-03-12 | 11.54M shares derived: average of 3 quarters · filed 2026-08-13 | 9.41M shares 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | 11.62M shares 10-Q · filed 2025-11-12 | 11.47M shares derived: average of 2 quarters · filed 2026-08-13 | 8.65M shares 10-Q · filed 2025-11-12 | 6.48M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | 11.33M shares 10-Q · filed 2026-08-13 | 7.14M shares 10-Q · filed 2026-08-13 | 4.77M shares derived: average of 3 quarters · filed 2026-08-13 | 3.61M shares derived: average of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | 2.84M shares 10-Q · filed 2026-05-14 | 1.49M shares derived: average of 2 quarters · filed 2026-05-14 | 1.04M shares derived: average of 3 quarters · filed 2026-05-14 | 806.60K shares derived: average of 4 quarters · filed 2026-05-14 | ||||
| 2024-12-31 | 139.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | 136.86K shares derived: average of 2 quarters · filed 2026-03-12 | 129.90K shares derived: average of 3 quarters · filed 2026-03-12 | 122.89K shares 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | 134.38K shares 10-Q · filed 2025-11-12 | 6.72M shares 10-Q · filed 2024-11-14 | 125.18K shares derived: average of 2 quarters · filed 2025-11-12 | 117.41K shares 10-Q · filed 2025-11-12 | 5.87M shares 10-Q · filed 2024-11-14 | -2.70M shares derived: average of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | 115.98K shares 10-Q · filed 2025-08-14 | 5.80M shares 10-Q · filed 2024-08-13 | 108.73K shares 10-Q · filed 2025-08-14 | 5.44M shares 10-Q · filed 2024-08-13 | -3.65M shares derived: average of 3 quarters · filed 2025-08-14 | -1.78M shares derived: average of 4 quarters · filed 2025-08-14 | ||
| 2024-03-31 | 101.45K shares 10-Q · filed 2025-05-19 | 5.07M shares 10-Q · filed 2024-05-21 | -5.53M shares derived: average of 2 quarters · filed 2025-05-19 | -2.41M shares derived: average of 3 quarters · filed 2025-05-19 | -848.17K shares derived: average of 4 quarters · filed 2025-05-19 | |||
| 2023-12-31 | -11.16M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-08 | -3.66M shares derived: average of 2 quarters · filed 2025-04-08 | -1.16M shares derived: average of 3 quarters · filed 2025-04-08 | 79.42K shares 10-K · filed 2025-04-08 | 3.97M shares 10-K · filed 2024-04-16 | |||
| 2023-09-30 | 3.84M shares 10-Q · filed 2024-11-14 | 3.83M shares derived: average of 2 quarters · filed 2024-11-14 | 3.83M shares 10-Q · filed 2024-11-14 | 3.82M shares derived: average of 4 quarters · filed 2024-11-14 | ||||
| 2023-06-30 | 3.83M shares 10-Q · filed 2024-08-13 | 3.82M shares 10-Q · filed 2024-08-13 | 3.82M shares derived: average of 3 quarters · filed 2024-08-13 | 3.82M shares derived: average of 4 quarters · filed 2024-08-13 | ||||
| 2023-03-31 | 3.81M shares 10-Q · filed 2024-05-21 | 3.81M shares derived: average of 2 quarters · filed 2024-05-21 | 3.81M shares derived: average of 3 quarters · filed 2024-05-21 | 3.81M shares derived: average of 4 quarters · filed 2024-05-21 | ||||
| 2022-12-31 | 3.81M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | 3.81M shares derived: average of 2 quarters · filed 2024-04-16 | 3.81M shares derived: average of 3 quarters · filed 2024-04-16 | 3.81M shares 10-K · filed 2024-04-16 | 76.23M shares 10-K · filed 2023-04-10 | |||
| 2022-09-30 | 3.81M shares 10-Q · filed 2023-11-20 | 76.23M shares 10-Q · filed 2022-11-14 | 3.81M shares derived: average of 2 quarters · filed 2023-11-20 | 3.81M shares 10-Q · filed 2023-11-20 | 76.23M shares 10-Q · filed 2022-11-14 | 21.93M shares derived: average of 4 quarters · filed 2023-11-20 | ||
| 2022-06-30 | 3.81M shares 10-Q · filed 2023-08-14 | 76.23M shares 10-Q · filed 2022-08-15 | 3.81M shares 10-Q · filed 2023-08-14 | 76.23M shares 10-Q · filed 2022-08-15 | 27.97M shares derived: average of 3 quarters · filed 2023-08-14 | 40.03M shares derived: average of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | 3.81M shares 10-Q · filed 2023-05-12 | 76.23M shares 10-Q · filed 2022-05-16 | 40.05M shares derived: average of 2 quarters · filed 2023-05-12 | 52.11M shares derived: average of 3 quarters · filed 2023-05-12 | 58.14M shares derived: average of 4 quarters · filed 2023-05-12 | |||
| 2021-12-31 | 76.29M shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-10 | 76.26M shares derived: average of 2 quarters · filed 2023-04-10 | 76.25M shares derived: average of 3 quarters · filed 2023-04-10 | 70.29M shares 10-K · filed 2023-04-10 | ||||
| 2021-09-30 | 76.23M shares 10-Q · filed 2022-11-14 | 76.23M shares derived: average of 2 quarters · filed 2022-11-14 | 68.29M shares 10-Q · filed 2022-11-14 | 55.36M shares derived: average of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | 76.23M shares 10-Q · filed 2022-08-15 | 64.26M shares 10-Q · filed 2022-08-15 | 48.40M shares derived: average of 3 quarters · filed 2022-08-15 | 38.56M shares derived: average of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | 52.16M shares 10-Q · filed 2022-05-16 | 34.49M shares derived: average of 2 quarters · filed 2022-05-16 | 26.00M shares derived: average of 3 quarters · filed 2022-05-16 | 21.63M shares derived: average of 4 quarters · filed 2022-05-16 | ||||
| 2020-12-31 | 16.83M shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-08 | 12.93M shares derived: average of 2 quarters · filed 2022-04-08 | 11.45M shares derived: average of 3 quarters · filed 2022-04-08 | 9.68M shares 10-K · filed 2022-04-08 | ||||
| 2020-09-30 | 9.03M shares 10-Q · filed 2021-11-15 | 8.76M shares derived: average of 2 quarters · filed 2021-11-15 | 7.29M shares 10-Q · filed 2021-11-15 | |||||
| 2020-06-30 | 8.49M shares 10-Q · filed 2021-08-16 | 6.42M shares 10-Q · filed 2021-08-16 | ||||||
| 2020-03-31 | 4.35M shares 10-Q · filed 2021-05-14 | |||||||
| 2019-12-31 | 2.04M shares 10-K · filed 2020-05-14 | |||||||
| 2019-03-31 | 17.51M shares 10-Q · filed 2019-05-15 | |||||||
| 2018-12-31 | 183.88K shares 10-K · filed 2020-05-14 | 12.87M shares 10-K · filed 2019-03-14 | ||||||
| 2018-03-31 | 10.12M shares 10-Q · filed 2019-05-15 | |||||||
| 2017-12-31 | 9.68M shares 10-K · filed 2019-03-14 | 77.43M shares 10-KT · filed 2018-03-26 | ||||||
| 2017-06-30 | 7.29M shares 10-K · filed 2019-03-14 | 58.29M shares 10-K · filed 2017-09-28 | ||||||
| 2016-12-31 | 48.99M shares 10-KT · filed 2018-03-26 | |||||||
| 2016-06-30 | 27.06M shares 10-KT · filed 2018-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |